153 related articles for article (PubMed ID: 19520186)
21. PPAR gamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation.
McCarty MF; Barroso-Aranda J; Contreras F
Med Hypotheses; 2008; 70(2):419-23. PubMed ID: 17548167
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells.
Sun WH; Chen GS; Ou XL; Yang Y; Luo C; Zhang Y; Shao Y; Xu HC; Xiao B; Xue YP; Zhou SM; Zhao QS; Ding GX
Cancer Lett; 2009 Mar; 275(2):247-55. PubMed ID: 19056168
[TBL] [Abstract][Full Text] [Related]
23. Pioglitazone, a PPAR-gamma ligand, exerts cytostatic/cytotoxic effects against cancer cells, that do not result from inhibition of proteasome.
Mrówka P; Głodkowska E; Młynarczuk-Biały I; Biały L; Kuckelkorn U; Nowis D; Makowski M; Legat M; Gołab J
Acta Biochim Pol; 2008; 55(1):75-84. PubMed ID: 18327303
[TBL] [Abstract][Full Text] [Related]
24. PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats.
Yang B; Lin P; Carrick KM; McNulty JA; Clifton LG; Winegar DA; Strum JC; Stimpson SA; Pahel GL
Biochem Biophys Res Commun; 2005 Aug; 334(1):176-82. PubMed ID: 15993383
[TBL] [Abstract][Full Text] [Related]
25. Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose.
Yang Z; Mo X; Gong Q; Pan Q; Yang X; Cai W; Li C; Ma JX; He Y; Gao G
Apoptosis; 2008 Nov; 13(11):1331-43. PubMed ID: 18780185
[TBL] [Abstract][Full Text] [Related]
26. Rotational co-culture of clonal β-cells with endothelial cells: effect of PPAR-γ agonism in vitro on insulin and VEGF secretion.
Paget MB; Murray HE; Bailey CJ; Flatt PR; Downing R
Diabetes Obes Metab; 2011 Jul; 13(7):662-8. PubMed ID: 21435140
[TBL] [Abstract][Full Text] [Related]
27. Pioglitazone reverses insulin resistance and impaired CCK-stimulated pancreatic secretion in eNOS(-/-) mice: therapy for exocrine pancreatic disorders?
Reddy RC; Hao Y; Lee SH; Gangireddy SR; Owyang C; DiMagno MJ
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G112-20. PubMed ID: 17510194
[TBL] [Abstract][Full Text] [Related]
28. High glucose induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.
Mather A; Chen XM; McGinn S; Field MJ; Sumual S; Mangiafico S; Zhang Y; Kelly DJ; Pollock CA
Int J Biochem Cell Biol; 2009 Mar; 41(3):561-9. PubMed ID: 18692592
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
Bernardo A; Bianchi D; Magnaghi V; Minghetti L
J Neuropathol Exp Neurol; 2009 Jul; 68(7):797-808. PubMed ID: 19535992
[TBL] [Abstract][Full Text] [Related]
30. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
Ghanaat-Pour H; Sjöholm A
Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603
[TBL] [Abstract][Full Text] [Related]
31. Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma.
Li X; Yang X; Xu Y; Jiang X; Li X; Nan F; Tang H
Cell Res; 2009 Jun; 19(6):720-32. PubMed ID: 19417774
[TBL] [Abstract][Full Text] [Related]
32. The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells.
Gensch C; Clever YP; Werner C; Hanhoun M; Böhm M; Laufs U
Atherosclerosis; 2007 May; 192(1):67-74. PubMed ID: 16876172
[TBL] [Abstract][Full Text] [Related]
33. The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways.
Boileau C; Martel-Pelletier J; Fahmi H; Mineau F; Boily M; Pelletier JP
Arthritis Rheum; 2007 Jul; 56(7):2288-98. PubMed ID: 17599749
[TBL] [Abstract][Full Text] [Related]
34. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.
Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J
Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559
[TBL] [Abstract][Full Text] [Related]
35. VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells.
Deissler H; Deissler H; Lang S; Lang GE
Br J Ophthalmol; 2008 Jun; 92(6):839-43. PubMed ID: 18511543
[TBL] [Abstract][Full Text] [Related]
36. A combination of a PPAR-gamma agonist and an angiotensin II receptor blocker attenuates proinflammatory signaling and stimulates expression of Smad7 in human peritoneal mesothelial cells.
Yao Q; Ayala ER; Qian JQ; Stenvinkel P; Axelsson J; Lindholm B
Clin Nephrol; 2007 Nov; 68(5):295-301. PubMed ID: 18044261
[TBL] [Abstract][Full Text] [Related]
37. Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.
Saulle E; Riccioni R; Coppola S; Parolini I; Diverio D; Riti V; Mariani G; Laufer S; Sargiacomo M; Testa U
Br J Haematol; 2009 May; 145(3):399-411. PubMed ID: 19245429
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin alphaVbeta3.
Liu L; Craig AW; Meldrum HD; Marcovina SM; Elliott BE; Koschinsky ML
Biochem J; 2009 Mar; 418(2):325-36. PubMed ID: 18821851
[TBL] [Abstract][Full Text] [Related]
39. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia.
Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y
Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113
[TBL] [Abstract][Full Text] [Related]
40. P-21-activated protein kinase-1 functions as a linker between insulin and Wnt signaling pathways in the intestine.
Sun J; Khalid S; Rozakis-Adcock M; Fantus IG; Jin T
Oncogene; 2009 Sep; 28(35):3132-44. PubMed ID: 19581924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
